Clinical TrialID 8464
Smell in COVID-19 and Efficacy of Nasal Theophylline (SCENT 3)
NCT05947643
COVID-19
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 8464
- Evidence Id
- 8464
- Core Evidence Id
- 8464
- Source Clinical Trial Id
- 8462
- Herb2 Clinical Trial Id
- HBCT008462
- Nct Id
- NCT05947643
- Title
- Smell in COVID-19 and Efficacy of Nasal Theophylline (SCENT 3)
- Status
- Active_Not_Recruiting
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- COVID-19
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: theophylline|DRUG: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Single_Group
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 41
- Outcome Measure
- Clinical Global Impression Scale (CGI), The CGI is a 3-item observer-rated scale that measures illness severity (CGIS), global improvement or change (CGIC). The CGI is rated on a 7-point scale, with the severity of illness scale using a range of responses from 1 (normal) through to 7 (amongst the most severely ill patients). CGI scores range from 1 (very much improved) through to 7 (very much worse). We will measure the response rate defined as the number of participants self-reporting minimal change or larger in the Clinical Global Impression Scale (CGI) scale, divided by the number of participants in each group., Week 6 and week 12 of treatment
- Sponsor Collaborator
- Washington University School of Medicine
- Funded By
- OTHER
- Location
- Washington University School of Medicine, Saint Louis, Missouri, 63110, United States
- Other Id
- 202209062
- Start Date
- 2022-11-22
- Primary Completion Date
- 2024-04-24
- Completion Date
- 2024-08-04
- First Posted
- 2023-07-17
- Results First Posted
- Last Update Posted
- 2024-07-10
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05947643
- Title Cn
- Title En
- Smell in COVID-19 and Efficacy of Nasal Theophylline (SCENT 3)
- Bilingual Status
- semi_complete